Home/Filings/4/0001209191-08-051954
4//SEC Filing

GREESON JANET 4

Accession 0001209191-08-051954

CIK 0001057377other

Filed

Sep 14, 8:00 PM ET

Accepted

Sep 15, 7:47 PM ET

Size

9.5 KB

Accession

0001209191-08-051954

Insider Transaction Report

Form 4
Period: 2008-09-11
GREESON JANET
DirectorChief Executive Officer
Transactions
  • Award

    Stock Optons (right to buy)

    2008-09-11+57,89557,895 total(indirect: NextGen LifeSciences, Inc.)
    Exercise: $0.19From: 2008-09-11Exp: 2010-09-11Common Stock (57,895 underlying)
  • Award

    Common Stock

    2008-09-11$0.20/sh+1,000,000$197,0001,000,000 total(indirect: NextGen LifeSciences DB Plan)
  • Disposition to Issuer

    Common Stock

    2008-09-11$0.20/sh1,000,000$197,000833,356 total(indirect: NextGen LifeSciences, Inc.)
Footnotes (1)
  • [F1]Option exercise price was equal or above the underlying stock price on grant date.

Issuer

SAMARITAN PHARMACEUTICALS INC

CIK 0001057377

Entity typeother

Related Parties

1
  • filerCIK 0001095218

Filing Metadata

Form type
4
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 7:47 PM ET
Size
9.5 KB